Class Action Alleges Fraudulent Marketing of Antidepressants

, The National Law Journal

   | 0 Comments

Forest Pharmaceuticals Inc. and Forest Laboratories Inc. are facing multiple proposed class actions in which the plaintiffs allege antidepressants Celexa and Lexapro were unlawfully marketed to treat adolescent depression.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202647848555

Thank you!

This article's comments will be reviewed.